PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹100 Cr | ₹61 Cr | ₹57 Cr | ₹45 Cr | ₹30 Cr |
What is the latest Contingent Liabilities ratio of PIRAMAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹61 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹45 Cr |
| Mar2021 | ₹30 Cr |
How is Contingent Liabilities of PIRAMAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 62.40 | |
| Mar2024 | ₹61 Cr | 7.17 | |
| Mar2023 | ₹57 Cr | 27.55 | |
| Mar2022 | ₹45 Cr | 49.90 | |
| Mar2021 | ₹30 Cr | - | |
Compare Contingent Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,357.1 Cr | -2.2% | -12.4% | -32.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,165.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -2.2% |
-12.4% |
-32.4% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses